Research field (3):
Digestive surgery
, Molecular biology
, Tumor biology
Research keywords (11):
cancer stroma
, cancer associated fibroblast
, adjuvant therapy
, neoadjuvant therapy
, surgery
, immunotherapy
, Gallbladder cancer
, bile duct cancer
, hepatocellular carcinoma
, cholangiocaricinoma
, pancreatic cancer
Research theme for competitive and other funds (7):
2021 - 2024 Bile cell-free DNAを用いゲノム多様性を標的にした胆道癌新規治療
2021 - 2024 胆管癌における休眠がん細胞のメカニズムの解明
2021 - 2024 A novel therapeutic strategy for pancreatic and biliary tract cancer by targeting the intestinal microbiota for anti-tumor immune activation
2020 - 2023 細胞外マトリックス阻害による腫瘍免疫活性化を目指した新規膵癌治療戦略
2020 - 2023 膵・胆道癌における染色体不安定性を標的とした革新的診断・免疫治療法の開発
2019 - 2021 A novel therapy to enhance the cancer immunity by remodeling tumor microenvironment in intrahepatic cholangiocarcinoma
Show all
Papers (116):
Masahiro Iseki, Masamichi Mizuma, Mitsuhiro Shimura, Takashi Kokumai, Hideaki Sato, Akiko Kusaka, Shuichi Aoki, Koetsu Inoue, Shun Nakayama, Daisuke Douchi, et al. Preoperative chemotherapy with Gemcitabine for pancreatic cancer causes zinc deficiency. Pancreas. 2024
Yuko Omori, Shuichi Aoki, Yusuke Ono, Takashi Kokumai, Shingo Yoshimachi, Hideaki Sato, Akiko Kusaka, Masahiro Iseki, Daisuke Douchi, Takayuki Miura, et al. Clonal analysis of metachronous double biliary tract cancers. The Journal of pathology. 2024. 263. 1. 113-127
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Zelong Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, et al. Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy. Cancer immunology research. 2024. 12. 4. 400-412
Yushi Inomata, Takeo Naito, Takashi Hiratsuka, Yusuke Shimoyama, Rintaro Moroi, Hisashi Shiga, Yoichi Kakuta, Kimiko Kayada, Yuki Ohara, Naoki Asano, et al. Rupture of ectopic varices of the ascending colon occurring after pancreatic cancer surgery: A case report and literature review. DEN open. 2024. 4. 1. e255
Blockade of PlGF inhibits ICC progression by targeting tumor-stroma interactions
(Annual Conference of Cholangiocarcinoma Foundation 2019)
Aberrant activation of placental growth factor/Neuropilin 1 pathway in intrahepatic cholangiocarcinoma: Therapeutic potential
(IASGO World Congress 2017)
Serum Carbohydrate Antigen 19-9 Values after Neoadjuvant Therapy Predict Survival of Patients with Pancreatic Adenocarcinoma: A Multicenter Case-Control Study of 269 Patients
(DDW 2015)
Clinicopathological features of distal cholangiocarcinoma: comparison between extra- and intrapancreatic bile duct
(Asian-Pacific Hepato-Pancreato-Biliary Association 2015)
The surgical anatomy of hilar hepatic artery in left-sided hepatectomy and caudate lobectomy for hilar cholangiocarcinoma
(International Surgical Week 2013)